Cangrelor for heart surgery when heparin causes low platelets
Part of Blood & lymphatic clinical trials.
This study tests a blood-thinning medicine called cangrelor for people with a rare complication where heparin causes a dangerous drop in platelets. It may help make heart surgery safer for those who cannot use heparin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a confirmed or very likely diagnosis of heparin-induced thrombocytopenia (HIT), which is a drop in blood platelets caused by the blood thinner heparin.
- You must be having heart or major blood vessel (aortic) surgery that uses a heart-lung machine.
- You will receive a study drug called cangrelor (helps prevent blood clots) during your surgery or shortly after.
- You must not object to your medical information being used for this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special filter (called Cytosorb) that may reduce bleeding during heart surgery by capturing the blood thinner ticagrelor from your blood. If you take ticagrelor and are scheduled for heart surgery with a bypass machine, this filter could help lower your risk of bleeding.
This study tests whether switching early to a weaker anti-platelet medicine based on your genetics can reduce bleeding problems in people at high risk for bleeding after a heart attack. It compares this approach to the usual strategy of staying on a stronger anti-platelet medicine.
This trial tests whether adding a fast-acting anti-clotting drug (cangrelor) helps people having a massive heart attack who need a heart-lung machine (VA-ECMO). The goal is to see if it reduces clotting risks without causing dangerous bleeding.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
This study looks at how well a certain blood thinner (cangrelor) works when used as a 'bridge' before surgery or another procedure. It is for people who already need to be on this medicine for a short time.
This trial tests if cangrelor, a fast-acting blood thinner, can prevent small vessel damage during a planned stent placement in patients with stable chest pain. It may help improve blood flow to the heart muscle.
Hear when a new Heparin-induced Thrombocytopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.